• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶栓相关颅内出血:对来自GUSTO-1试验的244例病例的影像学分析及临床相关性。链激酶和组织型纤溶酶原激活剂在冠状动脉闭塞中的全球应用。

Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

作者信息

Gebel J M, Sila C A, Sloan M A, Granger C B, Mahaffey K W, Weisenberger J, Green C L, White H D, Gore J M, Weaver W D, Califf R M, Topol E J

机构信息

Cleveland Clinic Foundation, Ohio 44195, USA.

出版信息

Stroke. 1998 Mar;29(3):563-9. doi: 10.1161/01.str.29.3.563.

DOI:10.1161/01.str.29.3.563
PMID:9506593
Abstract

BACKGROUND AND PURPOSE

Intracranial hemorrhage (ICH) is a serious complication of thrombolytic therapy. We systematically reviewed the radiographic features of 244 cases of symptomatic ICH complicating thrombolysis for acute myocardial infarction in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-1) trial, correlated these observations with clinical data, and speculated on hemorrhage pathogenesis.

METHODS

CT scans from 244 patients suffering symptomatic ICH were systematically reviewed for selected radiographic features, including ICH type, location, hematoma characteristics, mass effect features, hydrocephalus, and preexisting lesions. Hematoma volume was estimated by computer-assisted volumetric analysis. Data from this analysis were correlated with clinical data including hypertension, anticoagulation, age, thrombolytic regimen, and ICH timing.

RESULTS

Most hemorrhages were large (median [25th, 75th percentile] volume, 72 mL [39, 118]), solitary (66%), lobar (77%), confluent (80%), and intraparenchymal (82%) with a blood/fluid level (82%) and little edema (median [25th, 75th percentile] volume, 9 mL [5, 16]). Hydrocephalus (P<.001), any one mass effect feature (P<.001), intraventricular hemorrhage (P=.022), mottled hematoma appearance (P=.050), and hematoma blood/fluid level (P<.001) were associated with higher hemorrhage volume in the radiographic analysis, as were older age (P=.005), treatment with combined streptokinase and tissue plasminogen activator (P=.034), and hemorrhage onset 8 to 13 hours after treatment (P=.008) in the clinical analysis. Subdural hemorrhage was a high-volume subgroup whose risk increased with antecedent trauma (P=.026) or syncope (P=.006). Deep intraparenchymal hemorrhage was associated with hypertension (P=.016), and multifocal ICH occurred significantly earlier after treatment (P=.002).

CONCLUSIONS

Although the majority of postthrombolytic ICH are large, solitary, and supratentorial, the spectrum is diverse. Features of mass effect reflected the large volumes, and hematoma characteristics of mottling and blood/fluid levels were frequent. Thrombolysis-related coagulopathy and age appear to be the most important identifiable factors in the genesis of postthrombolytic ICH, but the hemorrhage subtype seen may reflect an interaction with other factors such as hypertension, ICH timing, antecedent head trauma, and syncope.

摘要

背景与目的

颅内出血(ICH)是溶栓治疗的严重并发症。我们系统回顾了全球应用链激酶和组织型纤溶酶原激活剂治疗闭塞冠状动脉(GUSTO-1)试验中244例急性心肌梗死溶栓治疗后发生症状性ICH的影像学特征,将这些观察结果与临床数据相关联,并推测出血的发病机制。

方法

对244例有症状性ICH患者的CT扫描进行系统回顾,以确定特定的影像学特征,包括ICH类型、位置、血肿特征、占位效应特征、脑积水和既往病变。通过计算机辅助容积分析估计血肿体积。该分析的数据与包括高血压、抗凝、年龄、溶栓方案和ICH发生时间在内的临床数据相关联。

结果

大多数出血量大(中位数[第25、75百分位数]体积,72 mL[39,118]),单发(66%),脑叶性(77%),融合性(80%),脑实质内(82%),有血液/液平面(82%),且水肿轻微(中位数[第25、75百分位数]体积,9 mL[5,16])。在影像学分析中,脑积水(P<0.001)、任何一种占位效应特征(P<0.001)、脑室内出血(P=0.022)、血肿呈斑点状外观(P=0.050)和血肿血液/液平面(P<0.001)与出血量较大相关;在临床分析中,年龄较大(P=0.005)、联合应用链激酶和组织型纤溶酶原激活剂治疗(P=0.034)以及治疗后8至13小时出血发作(P=0.008)也与出血量较大相关。硬膜下出血是一个高容量亚组,其风险随既往创伤(P=0.026)或晕厥(P=0.006)而增加。深部脑实质内出血与高血压相关(P=0.016),多灶性ICH在治疗后明显更早发生(P=0.002)。

结论

尽管大多数溶栓后ICH量大、单发且位于幕上,但表现多样。占位效应特征反映了出血量较大,血肿斑点状外观和血液/液平面特征较为常见。溶栓相关凝血障碍和年龄似乎是溶栓后ICH发生中最重要的可识别因素,但所见出血亚型可能反映了与其他因素如高血压、ICH发生时间、既往头部创伤和晕厥的相互作用。

相似文献

1
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.溶栓相关颅内出血:对来自GUSTO-1试验的244例病例的影像学分析及临床相关性。链激酶和组织型纤溶酶原激活剂在冠状动脉闭塞中的全球应用。
Stroke. 1998 Mar;29(3):563-9. doi: 10.1161/01.str.29.3.563.
2
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.糖尿病对急性心肌梗死溶栓时代临床结局的影响。GUSTO-I研究人员。链激酶和组织型纤溶酶原激活剂在闭塞冠状动脉中的全球应用。
J Am Coll Cardiol. 1997 Jul;30(1):171-9. doi: 10.1016/s0735-1097(97)00118-6.
3
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.糖尿病视网膜病变不应成为急性心肌梗死溶栓治疗的禁忌证:对GUSTO-I试验中眼内出血发生率及部位的回顾。全球应用链激酶和组织型纤溶酶原激活剂治疗冠状动脉闭塞。
J Am Coll Cardiol. 1997 Dec;30(7):1606-10. doi: 10.1016/s0735-1097(97)00394-x.
4
Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.急性心肌梗死患者接受rt-PA和肝素治疗后发生脑出血的临床特征及发病机制:心肌梗死溶栓治疗(TIMI)II期试点及随机临床试验联合经验
Neurology. 1995 Apr;45(4):649-58. doi: 10.1212/wnl.45.4.649.
5
Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator.冠状动脉用组织型纤溶酶原激活剂溶栓后的颅内出血
Am J Med. 1992 Apr;92(4):384-90. doi: 10.1016/0002-9343(92)90268-g.
6
Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.在当代急性心肌梗死溶栓治疗背景下动脉血压升高与死亡率及中风的关系。一项随机试验。GUSTO-I研究人员。
Ann Intern Med. 1996 Dec 1;125(11):891-900. doi: 10.7326/0003-4819-125-11-199612010-00004.
7
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.溶栓后早期再梗死:来自冠状动脉闭塞时链激酶和组织型纤溶酶原激活剂(阿替普酶)全球应用研究(GUSTO I)以及冠状动脉闭塞开通策略全球应用研究(GUSTO III)试验的经验。
Circulation. 2001 Sep 11;104(11):1229-35. doi: 10.1161/hc3601.095717.
8
Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.早期血管造影术无法预测溶栓后冠状动脉再闭塞:来自GUSTO血管造影研究的观察结果。链激酶和组织型纤溶酶原激活剂在闭塞冠状动脉中的全球应用。
J Am Coll Cardiol. 1994 Nov 15;24(6):1439-44. doi: 10.1016/0735-1097(94)90137-6.
9
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.接受溶栓治疗的急性心肌梗死女性和男性患者的特征及预后比较。GUSTO-I研究组。
JAMA. 1996 Mar 13;275(10):777-82.
10
Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.
Circulation. 1995 Nov 15;92(10):2811-8. doi: 10.1161/01.cir.92.10.2811.

引用本文的文献

1
Distance from main arteries influences microstructural and functional brain tissue characteristics.主要动脉的距离影响脑组织结构和功能特性。
Neuroimage. 2024 Jan;285:120502. doi: 10.1016/j.neuroimage.2023.120502. Epub 2023 Dec 14.
2
Clinical management and outcome of adult patients with extracorporeal life support device-associated intracerebral hemorrhage-a neurocritical perspective and grading.体外生命支持装置相关脑出血成人患者的临床管理和预后-神经重症监护视角和分级。
Neurosurg Rev. 2021 Oct;44(5):2879-2888. doi: 10.1007/s10143-020-01471-4. Epub 2021 Jan 23.
3
Prediction of stroke thrombolysis outcome using CT brain machine learning.
使用脑部CT机器学习预测中风溶栓结果
Neuroimage Clin. 2014 Mar 30;4:635-40. doi: 10.1016/j.nicl.2014.02.003. eCollection 2014.
4
Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?纤溶酶依赖性调节血脑屏障:tPA 诱导溶栓时的主要考虑因素?
J Cereb Blood Flow Metab. 2014 Aug;34(8):1283-96. doi: 10.1038/jcbfm.2014.99. Epub 2014 Jun 4.
5
Progress in translational research on intracerebral hemorrhage: is there an end in sight?脑出血转化医学研究的进展:有尽头吗?
Prog Neurobiol. 2014 Apr;115:45-63. doi: 10.1016/j.pneurobio.2013.09.007. Epub 2013 Oct 16.
6
Long-term outcomes of post-thrombolytic intracerebral hemorrhage in ischemic stroke patients.溶栓后缺血性脑卒中患者的颅内出血的长期预后。
Neurocrit Care. 2013 Apr;18(2):170-7. doi: 10.1007/s12028-012-9803-0.
7
Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage.原发性和抗栓相关脑出血的医学管理中的挑战和争议。
Ther Adv Neurol Disord. 2012 Jan;5(1):43-56. doi: 10.1177/1756285611422267.
8
Computer-assisted volumetric analysis compared with ABC/2 method for assessing warfarin-related intracranial hemorrhage volumes.计算机辅助容积分析与ABC/2法评估华法林相关颅内出血体积的比较。
Neurocrit Care. 2008;9(3):307-12. doi: 10.1007/s12028-008-9089-4.
9
Acute ischaemic stroke in patients aged 80 years and older: focus on the tolerability of thrombolytic agents.
Drugs Aging. 2008;25(2):95-103. doi: 10.2165/00002512-200825020-00002.
10
Early edema in warfarin-related intracerebral hemorrhage.华法林相关脑出血的早期水肿
Neurocrit Care. 2007;7(1):58-63. doi: 10.1007/s12028-007-0039-3.